These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1402620)

  • 1. Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study.
    Kristensen B; Ejlertsen B; Holmegaard SN; Krarup-Hansen A; Transbøl I; Mouridsen H
    J Intern Med; 1992 Sep; 232(3):237-45. PubMed ID: 1402620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in breast cancer patients after the first episode of hypercalcaemia.
    Kristensen B; Ejlertsen B; Mouridsen HT; Loft H
    J Intern Med; 1998 Sep; 244(3):189-98. PubMed ID: 9747741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of severe hypercalcaemia secondary to primary hyperparathyroidism: The efficacy of saline hydration, furosemide, and zoledronic acid.
    Oueslati I; Kardi A; Yazidi M; Abidi S; Chaker F; Mellassi S; Chihaoui M
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e380. PubMed ID: 36195995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour induced hypercalcaemia: a case for active treatment.
    O'Rourke NP; McCloskey EV; Kanis JA
    Clin Oncol (R Coll Radiol); 1994; 6(3):172-6. PubMed ID: 8086352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD).
    Grutters JC; Hermus AR; de Mulder PH; Beex LV
    Breast Cancer Res Treat; 1993; 25(3):277-81. PubMed ID: 8369528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled study.
    Hasling C; Charles P; Mosekilde L
    Eur J Clin Invest; 1986 Oct; 16(5):433-7. PubMed ID: 3100312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of malignant hypercalcaemia.
    Stevenson JC
    Drugs; 1988 Aug; 36(2):229-38. PubMed ID: 3053127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
    Rotstein S; Glas U; Eriksson M; Pfeiffer P; Hansen J; Söderqvist J; Bandmann U; Strid S
    Eur J Cancer; 1992; 28A(4-5):890-3. PubMed ID: 1388038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease.
    Thalassinos NC; Joplin GF
    Lancet; 1970 Sep; 2(7672):537-8. PubMed ID: 4195203
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
    Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
    Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rehydration in the treatment of severe hypercalcaemia.
    Hosking DJ; Cowley A; Bucknall CA
    Q J Med; 1981; 50(200):473-81. PubMed ID: 7342172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous fat necrosis with hypercalcemia.
    Vijayakumar M; Prahlad N; Nammalwar BR; Shanmughasundharam R
    Indian Pediatr; 2006 Apr; 43(4):360-3. PubMed ID: 16651678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
    Nikolic-Tomasević Z; Jelic S; Popov I; Radosavljević D; Mitrović L
    Oncology; 2001; 60(2):123-6. PubMed ID: 11244326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pamidronate in the treatment of tumor-associated hypercalcemia].
    Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
    Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
    Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
    Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and hypercalcaemia.
    Daugaard G
    Ann Oncol; 1993 Sep; 4(8):683-7. PubMed ID: 8241000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcaemia in patients with advanced mammary cancer.
    Galasko CS; Burn JI
    Br Med J; 1971 Sep; 3(5774):573-7. PubMed ID: 5571456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.